3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
20
Lymphoma, Mantle-Cell
13
Burkitt Lymphoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell, Marginal Zone
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Lymphoma, Follicular
6
Lymphoma, B-Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Hairy Cell
2
Blast Crisis
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, T-Cell
1
Lymphoma, AIDS-Related
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Chronic-Phase
1
Hematopoietic and Lymphoid System Neoplasm
1
Composite Lymphoma
1
Classic Follicular Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Cyclophosphamide
12
fludarabine phosphate
7
fludarabine
7
venetoclax
6
blinatumomab
6
Cytarabine
5
Lenalidomide
4
Dexamethasone
4
Blood Specimen Collection
4
Azacitidine
4
obinutuzumab
3
Rituximab
3
Radiotherapy
3
Melphalan
3
Immunotherapy, Adoptive
3
pembrolizumab
2
daratumumab
2
Neoadjuvant Therapy
2
Idarubicin
2
Chemotherapy, Adjuvant
2
Capecitabine
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
tagraxofusp
1
sacituzumab govitecan
1
sabatolimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
CT-P10
×
1 year
×
Clear all
No trials found.